Status
Conditions
Treatments
About
To scientifically demonstrate the improvements in cognitive functions and core symptoms of children and adolescents diagnosed with ADHD through the implementation of a cognitive rehabilitation program based on the use of the most relevant technologies found in the systematic review carried out during the first phase.
Two intervention groups will be randomly assigned for the study:
G1: composed of 20 patients who will receive neurocognitive therapy based on new technologies. This will be the experimental group.
G2: composed of 20 patients who will receive conventional neurocognitive therapy for ADHD treatment. This group will be the control group
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal